Advancements in delivery systems for in vivo chimeric antigen receptor T-cell therapy in urological diseases
{{output}}
Chimeric antigen receptor (CAR) T-cell therapy is a new type of highly precise and targeted immunotherapy for urological diseases. It has demonstrated significant therapeutic potential in chronic and autoimmune kidney diseases such as renal fibrosis and membra... ...
